Status:
COMPLETED
A Trial to Reduce Delirium in Aged Post Acute Patients
Lead Sponsor:
National Institute on Aging (NIA)
Collaborating Sponsors:
Paul B. Beeson Career Development Awards in Aging Research Program
Conditions:
Delirium
Aging
Eligibility:
All Genders
65+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to develop a comprehensive Delirium Abatement Program of care of delirious patients in the post acute care setting and to evaluate its impact on persistence and severity o...
Detailed Description
Common, morbid, and costly, delirium affects one third of hospitalized elders, and plays a central role in the cascade of adverse events that leads to functional decline and loss of independence. More...
Eligibility Criteria
Inclusion
- Admission to study site following acute care medical/surgical hospitalization
- Aged 65 or older
- English-speaking
- Communicative prior to acute illness
- Not admitted for terminal care (life expectancy greater than 6 months)
- Residence within 25 miles of research site
Exclusion
- Significant hearing impairment which precludes interviews
- End stage dementia (complete ADL dependence)
- Previous study enrollment
Key Trial Info
Start Date :
May 1 2000
Trial Type :
INTERVENTIONAL
End Date :
June 1 2004
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00182936
Start Date
May 1 2000
End Date
June 1 2004
Last Update
November 20 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hebrew Rehabilitation Center for Aged
Boston, Massachusetts, United States, 02131